Philips Respironics has unveiled the groundbreaking Simply Go Mini, a state-of-the-art portable oxygen concentrator specifically engineered to empower patients requiring oxygen therapy.

In a viral clip, a man warns this model of Philips CPAP machine could cause cancer. Is he right, and are there other models to worry about?

(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers.

However, Philips Respironics has not received any specific complaints of device malfunctions resulting from in-line nebulizer use so far, and no patient deaths have been reported.

Philips Respironics, Inc. has issued updated instructions for the use of its OmniLab Advanced+ (OLA+) Ventilator because of its demonstrated failure in the ventilator inoperative alarm that can ...

Learn about upgrades in Koninklijke Philips N.V. stock and their outlook for 2024, including sales growth targets and potential upside. Click for my PHG update.

Philips Respironics is in the process of closing some facilities in western Pennsylvania.Related video above: The fight to replace recalled Philips CPAP machine A spokesperson confirmed to ...

Philips received a warning letter from the FDA in February, which the Agency posted on Tuesday, stating that an inspection of the tech giant's manufacturing facility in Suzhou, China, that makes CT ...

Philips Respironics agreed to pay $1.1 billion to address claims filed in US courts and potential claims submitted through the census registry; the company has not admitted any fault or liability ...

Philips Respironics announced that it agreed to pay over a billion dollars to settle claims stemming from the 2021 U.S. recall of its sleep therapy devices.

Philips settles $1.1 billion in Respironics ventilator recall lawsuit. Updates on Philips' Q1 performance and 2024 guidance. PHG shares surge 36.9% in premarket trading.

Philips has reached a $1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year guidance.